COMPANY STOCKHOLDER SUPPORT AGREEMENTCompany Stockholder Support Agreement • October 31st, 2022 • Phoenix Biotech Acquisition Corp. • Blank checks
Contract Type FiledOctober 31st, 2022 Company IndustryThis COMPANY STOCKHOLDER SUPPORT AGREEMENT (this “Agreement”), dated as of October 30, 2022, is made by and among Phoenix Biotech Acquisition Corp., a Delaware corporation (“Parent”), Intrinsic Medicine, Inc., a Delaware corporation (the “Company”), and each of the undersigned holders (together with each such holder who executes a signature page to this Agreement after the date hereof, collectively, the “Holders”) of capital stock of the Company. Each of Parent, the Company and the Holders may hereinafter be referred to as a “Party” and collectively, as the “Parties.”
BUSINESS COMBINATION AGREEMENT BY AND AMONG PHOENIX BIOTECH ACQUISITION CORP., OM MERGER SUB, INC. AND INTRINSIC MEDICINE, INC. DATED AS OF OCTOBER 30, 2022Business Combination Agreement • October 31st, 2022 • Phoenix Biotech Acquisition Corp. • Blank checks • New York
Contract Type FiledOctober 31st, 2022 Company Industry JurisdictionThis BUSINESS COMBINATION AGREEMENT (this “Agreement”), dated as of October 30, 2022, is made by and among Phoenix Biotech Acquisition Corp., a Delaware corporation (“SPAC”), OM Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Intrinsic Medicine, Inc., a Delaware corporation (the “Company”). SPAC, Merger Sub and the Company shall be referred to herein from time to time collectively as the “Parties” (and each a “Party”). Capitalized terms used herein have the meanings set forth in Section 1.1 and Section 1.2.
SPONSOR SUPPORT AGREEMENTSponsor Support Agreement • October 31st, 2022 • Phoenix Biotech Acquisition Corp. • Blank checks
Contract Type FiledOctober 31st, 2022 Company IndustryThis SPONSOR SUPPORT AGREEMENT (this “Agreement”), dated as of October 30, 2022, is made by and among Phoenix Biotech Sponsor, LLC, a Delaware limited liability company (the “Sponsor”) as the sole holder of Class B common stock, par value $0.0001 per share (the “Class B Common Stock”), of Phoenix Biotech Acquisition Corp., a Delaware corporation (“SPAC”), solely for purposes of Section 5 of this Agreement, the other Persons party hereto as “Other SPAC Insiders” set forth on the signature pages hereto (the “Other SPAC Insiders,” and together with the Sponsor, collectively, the “SPAC Insiders”), SPAC, and Intrinsic Medicine, Inc., a Delaware corporation (the “Company”). The Sponsor, SPAC and the Company shall be referred to herein from time to time collectively as the “Parties.” Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Business Combination Agreement (as defined below).